Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The AAPS Journal|January 16, 2009
The use of clinical utility assessments in early clinical developmentAnis A Khan, Itay Perlstein, Rajesh Krishna
Journal of Pharmaceutical Sciences|November 16, 2002
A signal transduction pharmacodynamic model of the kinetics of the parasympathomimetic activity of low-dose scopolamine and atropine in ratsItay Perlstein, David Stepensky, Wojciech Krzyzanski, et al.
The AAPS Journal|September 19, 2009
Evaluation of agile designs in first-in-human (FIH) trials--a simulation studyItay Perlstein, James A Bolognese, Rajesh Krishna, et al.
Clinical Therapeutics|July 20, 2015
Relative Bioavailability of Apixaban Solution or Crushed Tablet Formulations Administered by Mouth or Nasogastric Tube in Healthy SubjectsYan Song, Xiaoli Wang, Itay Perlstein, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 16, 2002
Scaling vs. nonscaling methods of assessing autonomic tone in streptozotocin-induced diabetic ratsItay Perlstein, Nir Sapir, Joshua Backon, et al.
Journal of Clinical Pharmacology|January 7, 2026
Population Pharmacokinetic Model-Based Dose Selection of Extended-Release Injectable Olanzapine (TV-44749) for Subcutaneous Use in Phase 3 Clinical Trial in Adults with SchizophreniaItay Perlstein, Irina Cherniakov, Anna Elgart, et al.
Frontiers in Neurology|November 28, 2022
The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development programPeter A LeWitt, Fabrizio Stocchi, David Arkadir, et al.
Human Gene Therapy|July 8, 2005
Posttranslational control of a cardiac ion channel transgene in vivo: clarithromycin-hMiRP1-Q9E interactionsItay Perlstein, Denise Y Burton, Kenneth Ryan, et al.
CNS Drugs|April 12, 2018
ND0701, A Novel Formulation of Apomorphine for Subcutaneous Infusion, in Comparison to a Commercial Apomorphine Formulation: 28-Day Pharmacokinetic Study in Minipigs and a Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Relative BioavailabilityYuval Ramot, Abraham Nyska, Liat Adar, et al.
Advances in Therapy|September 8, 2025
Switching Patients with Schizophrenia from Intramuscular Paliperidone Palmitate Once Monthly to TV-46000, a Long-Acting Subcutaneous Antipsychotic: Population Pharmacokinetic-Based StrategiesItay Perlstein, Jonathan Meyer, Ziqi Yue, et al.
Pageof 2